Pharmos(PARS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Pharmos(PARS)

PARS 2.700

+13.6%

Jan 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Zvi Steinberg who wrote (989)	7/14/1998 12:41:00 PM
From: Ariella	Read Replies (3) of 1491

Dear Zvi -- what a mixed blessing this article is -- nice to have PARS so strongly represented. On the other hand, that last line in paragraph one raised my eyebrows: << If everything goes as planned, Pharmos expects to submit the drug to the US Food and Drug Administration for approval in three to four years. >> This looks like 2 years or so behind what other followers of PARS have forecast. A very big difference. --Ariella

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next